Purpose or Objective: Although intensity modulated radiotherapy (IMRT) permits the delivery of a highly conformal dose to target volumes while sparing dose to identified organs at risk, it results in a higher whole body integral dose due to irradiation of a larger volume of tissue at lower doses. A randomized clinical trial in head and neck cancer comparing IMRT with 3-D conformal radiotherapy, demonstrated higher acute fatigue in the IMRT cohort, raising the possibility of an association with higher integral dose. We hypothesized that a higher integral whole body dose is associated with worsening fatigue and an adverse functional outcome in patients with localized prostate cancer treated with intensity modulated external beam radiotherapy.
Results:
The median integral dose was 119.7 litre-Gy (range 90.5 -168.1). In the whole population 17/26 (65%) had worsening of fatigue, physical or role functioning. A significantly higher proportion of patients with an integral dose above median had worsening fatigue, physical and role functioning compared with patients with an integral dose below median. (6/13 versus 11/13; z test for proportions p=0.04).
Conclusion:
To our knowledge, this is the first study linking acute worsening of fatigue and functional outcome with whole body integral dose. Further validation in a larger cohort and in different tumour sites is necessary and the relationship between integral dose and toxicity merits further investigation.
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Intestinal toxicity from WPRT delivered with IMRT is negligible. A multicentric observational trial. 
Material and Methods:
In 2014 a multicentric, observational trial aimed at assessing IT from RT including WPRT was activated. Prior to study activation, a pilot feasibility study was started in the coordinating Institute. For the study's purpose, the IBDQ is to be filled in by pts at baseline, RT mid-point and end, 3 and 6 months, and thereafter every 6 months up to 5 years. The questionnaire comprises 32 items investigating bowel symptoms (10 items), emotional health (12), systemic symptoms (5) and social function (5). The responses are scored on a seven-point scale in which 7 corresponds to the best function and 1 to the worst. Average per item scores can be calculated for each of the 4 domains. This analysis pertains to the first 144 pts (8 Institutes) with complete data available at baseline, RT mid-point and end. Initially, only pts treated with post-prostatectomy RT with either adjuvant (ADV, n= 71) or salvage (SALV, n= 73) intent were enrolled. Pts were treated with static-field IMRT (n = 31), Tomotherapy (n = 42) and VMAT (n = 71), with conventional (1.8-2 Gy/fr, n = 78) or moderate hypofractionation (2.15-2.65 Gy/fr, median 2.35, n=66). The median EQD2 dose to the prostatic bed and pelvic lymphnodal area was 71.2 and 50 Gy, respectively. 58 pts received concomitant androgen deprivation.
Results:
Overall, self-perceived intestinal toxicity from WPRT was mild: mean scores for bowel symptoms at baseline, RT mid-point and end were in fact 6.58, 6.09, 5.90 (repeated measures Anova, p<0.0001), for emotional health 5. 94,5.79,5.69 (0.0003), for social function 6.20, 5.83, 5.65 (p<0.0001) and for systemic symptoms 5. 95, 5.55, 5.40 (p<0.0001) , respectively. For the evaluation of acute toxicity, the worst variation (delta) between baseline and RT midpoint or end was considered. With respect to the bowel symptoms, the median score decrease (worsening) was 2 points for only one item (frequent bowel movements), 1 point for loose bowel movements, gas passage, abdominal bloating and urge to defecate, and 0 for abdominal pains and cramps, rectal bleeding, accidental soiling and nausea. Nevertheless, abdominal pain and urge to defecate were the two items with higher predictive power (AUC 72-79% at ROC curve analysis) with respect to a worsening of ³1 point (25th percentile) of either emotional or systemic or social domains, as well as gas passage, urge to defecate and nausea (AUC 72-73%) for emotional.
Conclusion:
The self assessed AIT from WPRT delivered by means of modern IMRT technique is negligible. Abdominal pain and urge to defecate are the 2 symptoms mostly correlated with a worsening of patient's QoL.
PO-0756
Choline PET/CT and Stereotactic Body Radiotherapy in oligometastatic prostate cancer patients F. Pasqualetti 1 , M. Panichi 1 , A. Sainato 1 , F. Matteucci 1 , L. Derosa 2 , P. Cocuzza 1 , G. Coraggio 1 , P. Ferrazza 1 , S.
